Please try another search
Alexandria Co. For Pharmaceuticals & Chemical Industries reported earnings results for the first quarter ended September 30, 2023. For the first quarter, the company reported revenue was EGP 487.86 million compared to EGP 342.97 million a year ago. Net income was EGP 59.18 million compared to EGP 34.59 million a year ago.
Period Ending: | Sep 30, 2023 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 |
---|---|---|---|---|
Total Revenue | 486.48 | 342.96 | 374.37 | 265.36 |
Gross Profit | 104.53 | 72.75 | 99.25 | 47.88 |
Operating Income | 76 | 67.67 | 24.87 | |
Net Income | 59.18 | 48.64 | 23.04 |
Period Ending: | Sep 30, 2023 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 |
---|---|---|---|---|
Total Assets | 183.9 | 875.21 | 831.24 | |
Total Liabilities | -535.42 | 262.6 | 231.33 | |
Total Equity | 719.32 | 612.6 | 612.6 | 599.92 |
Period Ending: | Sep 30, 2023 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 |
---|---|---|---|---|
Period Length: | 0 Months | 0 Months | 0 Months | 0 Months |
Cash From Operating Activities | 54.26 | 111.28 | -0.946 | |
Cash From Investing Activities | -8.58 | -2.15 | -4.52 | |
Cash From Financing Activities | -0.122 | -10.14 | -20.86 | |
Net Change in Cash | 45.56 | 98.99 | -26.33 |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review